Preview

Вестник рентгенологии и радиологии

Расширенный поиск

Хронический аспергиллез легких: обзор литературы и демонстрация собственных наблюдений

https://doi.org/10.20862/0042-4676-2021-102-5-317-328

Полный текст:

Аннотация

Хронический аспергиллез легких (ХАЛ) – тяжелое заболевание, развивающееся преимущественно у пациентов без выраженных нарушений иммунного статуса. Компьютерная томография является основным инструментальным методом диагностики ХАЛ, необходимым для определения формы заболевания, выбора тактики лечения, контроля осложнений и мониторинга терапии. Это обусловливает важность понимания рентгенологом основных аспектов своевременной и дифференциальной диагностики. Отечественных исследований по этой проблеме недостаточно. В данной работе проведен анализ российских и зарубежных публикаций за период 2014–2020 гг., представленных в электронных базах данных PubMed, Web of Science, Elsevier, eLibrary. При поиске информации использованы следующие ключевые слова: computed tomography, chronic pulmonary aspergillosis, aspergilloma, air-crescent symptom, differential diagnosis.

Об авторах

Н. Г. Николаева
ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава
Россия

Николаева Наталия Георгиевна, аспирант кафедры лучевой диагностики и лучевой терапии, врач-рентгенолог кабинета компьютерной томографии клиники им. Э.Э. Эйхвальда

ул. Кирочная, 41, Санкт-Петербург, 191015



О. В. Шадривова
ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава
Россия

Шадривова Ольга Витальевна, к. м. н., доцент кафедры клинической микологии, аллергологии и иммунологии

ул. Кирочная, 41, Санкт-Петербург, 191015



И. Э. Ицкович
ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава
Россия

Ицкович Ирина Эммануиловна, д. м. н., профессор, заведующая кафедрой лучевой диагностики и лучевой терапии, заведующая рентгеновским отделением клиники им. Э.Э. Эйхвальда

ул. Кирочная, 41, Санкт-Петербург, 191015



Н. Н. Климко
ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава
Россия

Климко Николай Николаевич, д. м. н., профессор, заведующий кафедрой клинической микологии, аллергологии и иммунологии

ул. Кирочная, 41, Санкт-Петербург, 191015



Список литературы

1. Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016; 47(1): 45–68. https://doi.org/10.1183/13993003.00583-2015.

2. Klimko N, Kozlova Y, Khostelidi S, et al. The burden of serious fungal diseases in Russia. Mycoses. 2015; 58(5): 58–62. https://doi.org/10.1111/myc.12388.

3. Osmanov A, Denning DW. Burden of serious fungal infections in Ukraine. Mycoses. 2015; 58(5): 94–100. https://doi.org/10.1111/myc.12409.

4. Bobokhojaev OI, Osmanov A, Aliev SP, et al. The burden of serious fungal infections in Tajikistan. J Fungi (Basel). 2019; 5(3): 68. https://doi.org/10.3390/jof5030068.

5. Lowes D, Al-Shair K, Newton PJ, et al. Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J. 2017; 49(2): 1601062. https://doi.org/10.1183/13993003.01062-2016.

6. Kosmidis C, Muldoon EG. Challenges in the management of chronic pulmonary aspergillosis. Med Mycol. 2017; 55(1): 63–8. https://doi.org/10.1093/mmy/myw119.

7. Laursen CB, Davidsen JR, Van Acker L, et al. CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry. J Fungi (Basel). 2020; 6(3): 96. https://doi.org/10.3390/jof6030096.

8. Готман Л.Н., Юдин А.Л., Яцык Г.А. Ранние компьютерно-томографические признаки аспергиллеза легких при миелотоксическом агранулоцитозе. Медицинская визуализация. 2008; 3: 78–83. [Gotman LN, Yudin AL, Yatsyk GA. The early CT-signs of pulmonary aspergillosis at myelotoxic agranulocytosis. Medical Visualization. 2008; 3: 78–83 (in Russ.).]

9. Трофимова Т.Н., Климко Н.Н., Самохвалова М.В. Лучевая диагностика инвазивного аспергиллеза легких. Медицинская визуализация. 2008; 2: 44–51. [Trofimova TN, Klimko NN, Samokhvalova MV. Diagnostic imaging of invasive pulmonary aspergillosis. Medical Visualization. 2008; 2: 44–51 (in Russ.).]

10. Maghrabi F, Denning DW. The management of chronic pulmonary aspergillosis: The UK National Aspergillosis Centre approach. Curr Fungal Infect Rep. 2017; 11(4): 242–51. https://doi.org/10.1007/s12281-017-0304-7.

11. Paulussen C, Hallsworth JE, Alvarez-Perez S, et al. Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species. Microb Biotechnol. 2017; 10(2): 296–322. https://doi.org/10.1111/1751-7915.12367.

12. Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017; 17(11): 357–66. https://doi.org/10.1016/S1473-3099(17)30309-2.

13. Moazam S, Denning DW. Aspergillus nodules in chronic granulomatous disease attributable to Aspergillus ochraceus. Med Mycol Case Rep. 2017; 17: 31–3. https://doi.org/10.1016/j.mmcr.2017.06.004.

14. Larkin PM, Multani A, Beaird OE, et al. Collaborative tale of diagnosing and treating chronic pulmonary aspergillosis, from the perspectives of clinical microbiologists, surgical pathologists, and infectious disease clinicians. J Fungi (Basel). 2020; 6(3): 106. https://doi.org/10.3390/jof6030106.

15. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015; 70(3): 270–7. https://doi.org/10.1136/thoraxjnl-2014-206291.

16. Sehgal IS, Choudhary H, Dhooria S, et al. Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis. Mycoses. 2018; 61(10): 770–6. https://doi.org/10.1111/myc.12815.

17. Li H, Rui Y, Zhou W, et al. Role of the Aspergillus-specific IgG and IgM test in the diagnosis and follow-up of chronic pulmonary aspergillosis. Front Microbiol. 2019; 10: 1438. https://doi.org/10.3389/fmicb.2019.01438.

18. Sehgal IS, Dhooria S, Choudhary H, et al. Efficiency of a fumigatus-specific IgG and galactomannan testing in the diagnosis of simple aspergilloma. Mycoses. 2019; 62(12): 1108–15. https://doi.org/10.1111/myc.12987.

19. Page ID, Richardson M, Denning DW. Antibody testing in aspergillosis – quo vadis? Med Mycol. 2015; 53(5): 417–39. https://doi.org/10.1093/mmy/myv020.

20. Sehgal IS, Dhooria S, Choudhary H, et al. Utility of serum and bronchoalveolar lavage fluid galactomannan in diagnosis of chronic pulmonary aspergillosis. J Clin Microbiol. 2019; 57(3): e01821–18. https://doi.org/10.1128/JCM.01821-18.

21. Page ID, Richardson MD, Denning DW. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). J Infect. 2016; 72(2): 240–9. https://doi.org/10.1016/j.jinf.2015.11.003.

22. Page ID, Byanyima R, Hosmane S, et al. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Eur Respir J. 2019; 53(3): 1801184. https://doi.org/10.1183/13993003.01184-2018.

23. Sehgal IS, Dhooria S, Muthu V, et al. An overview of the available treatments for chronic cavitary pulmonary aspergillosis. Expert Rev Respir Med. 2020; 14(7): 715–27. https://doi.org/10.1080/17476348.2020.1750956.

24. Méchaï F, Fock-Yee C, Bouvry D, et al. Pulmonary tuberculosis: radiological evolution of broncho-pulmonary lesions at the end of treatment. Rev Mal Respir. 2019; 36(1): 22–30. https://doi.org/10.1016/j.rmr.2018.08.005.

25. Khan R, Malik NI, Razaque A. Imaging of pulmonary posttuberculosis sequelae. Pak J Med Sci. 2020; 36(1): S75–82. https://doi.org/10.12669/pjms.36.ICON-Suppl.1722.

26. Евсеев П.Ю., Белоказанцева В., Кондакова М.Н. и др. Хронический аспергиллез у пациентов с деструктивным туберкулезом легких. Проблемы медицинской микологии. 2018; 20(4): 24–6. [Evseev PY, Belokazanceva V, Kondakova MN, et al. Chronic aspergillosis in adult patients with chronic destructive pulmonary tuberculosis. Problems in Medical Mycology. 2018; 20(4): 24–6 (in Russ.).]

27. Denning DW, Page ID, Chakaya J, et al. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018; 24(8): e171312. https://doi.org/10.3201/eid2408.171312.

28. Naito M, Kurahara Y, Yoshida S, et al. Prognosis of chronic pulmonary aspergillosis in patients with pulmonary nontuberculous mycobacterial disease. Respir Investig. 2018; 56(4): 326–31. https://doi.org/10.1016/j.resinv.2018.04.002.

29. Denning DW. Sarcoidosis and aspergillosis: a tough combination. Eur Respir J. 2017; 49(6): 1700574. https://doi.org/10.1183/13993003.00574-2017.

30. Uzunhan Y, Nunes H, Jeny F, et al. Chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J. 2017; 49(6): 1602396. https://doi.org/10.1183/13993003.02396-2016.

31. Fujiuchi S, Fujita Y, Suzuki H, et al. Cavitary formation in nontuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis. Eur Respir J. 2014; 44(Suppl 58): P2491.

32. Takeda K, Imamura Y, Takazono T, et al. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol. 2016; 54(2): 120–7. https://doi.org/10.1093/mmy/myv093.

33. Jhun BW, Jung WJ, Hwang NY, et al. Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease. PLoS One. 2017; 12(11): e0188716. https://doi.org/10.1371/journal.pone.0188716.

34. Козлова Я.И., Борзова Ю.В., Шадривова О.В. и др. Аспергиллез легких у больных муковисцидозом в Российской Федерации. Журнал инфектологии. 2018; 10(2): 48–54. https://doi.org/10.22625/2072-6732-2018-10-2-48-54. [Kozlova YaI, Borzova YuV, Shadrivova OV, et al. Pulmonary aspergillosis in patients with cystic fibrosis in Russian Federation. Journal of Infectology. 2018; 10(2): 48–54 (in Russ.). https://doi.org/10.22625/2072-6732-2018-10-2-48-54.]

35. Шпагина Л.А., Паначева Л.А., Куделя Л.М. и др. Аспергиллез легких среди рабочих высокого профессионального риска. Пульмонология. 2014; 1: 113–5. https://doi.org/10.18093/0869-0189-2014-0-1-113-115. [Shpagina LA, Panacheva LA, Kudelya LM, et al. Pulmonary aspergillosis in workers with high occupational risk. Pulmonologiya. 2014; 1: 113–5 (in Russ.). https://doi.org/10.18093/0869-0189-2014-0-1-113-115.]

36. Трофименко И.Н., Нашатырева М.С., Черняк Б.А. Поражение легких при анкилозирующем спондилите. Пульмонология. 2017; 27(1): 97–102. https://doi.org/10.18093/0869-0189-2017-27-1-97-102. [Trofimenko IN, Nashatyreva MS, Chernyak BA. Pulmonary involvement in ankylosing spondylitis. Pulmonologiya. 2017; 27(1): 97–102 (in Russ.). https://doi.org/10.18093/0869-0189-2017-27-1-97-102.]

37. Desai SR, Hedayati V, Patel K, Hansell DM. Chronic aspergillosis of the lungs: unravelling the terminology and radiology. Eur Radiol. 2015; 25(10): 3100–7. https://doi.org/10.1007/s00330-015-3690-7.

38. Tamura A, Suzuki J, Fukami T, et al. Chronic pulmonary aspergillosis as a sequel to lobectomy for lung cancer. Interact Cardiovasc Thorac Surg. 2015; 21(5): 650–6. https://doi.org/10.1093/icvts/ivv239.

39. Panse P, Smith M, Cummings K, et al. The many faces of pulmonary aspergillosis: Imaging findings with pathologic correlation. Radiol Infect Dis. 2016; 3(4): 192–200. https://doi.org/10.1016/j.jrid.2016.10.002.

40. Sevilha JB, Rodrigues RS, Barreto MM, et al. Infectious and noninfectious diseases causing the air crescent sign: a state-ofthe- art review. Lung. 2018; 196(1): 1–10. https://doi.org/10.1007/s00408-017-0069-3.

41. Gazzoni FF, Severo LC, Marchiori E, et al. Pulmonary diseases with imaging findings mimicking aspergilloma. Lung. 2014; 192(3): 347–57. https://doi.org/10.1007/s00408-014-9568-7.

42. Marchiori E, Hochhegger B, Zanetti G. Intracavitary nodule in active tuberculosis: differential diagnosis of aspergilloma. J Bras Pneumol. 2015; 41(6): 562–3. https://doi.org/10.1590/S1806-37562015000000211.

43. Taoka T, Shinohara T, Naruse K, Ogushi F. Cavitary lung cancer with cartilage tissues in the wall mimicking aspergilloma. Thorax. 2017; 72(4): 383–4. https://doi.org/10.1136/thoraxjnl-2016-209437.

44. Demirtaş H, Çelik AO, Kayan M, et al. Aspergilloma mimicking metastasis in a case with laryngeal carcinoma. Med Arch. 2016; 70(1): 76–8. https://doi.org/10.5455/medarh.2016.70.76-78.

45. Tunney R, Rodger K, Denning DW, Kosmidis C. Chronic pulmonary aspergillosis following pulmonary embolism. Med Mycol Case Rep. 2019; 23: 20–2. https://doi.org/10.1016/j.mmcr.2018.11.002.

46. Higashi Y, Nakamura S, Ashizawa N, et al. Pulmonary actinomycosis mimicking pulmonary aspergilloma and a brief review of the literature. Intern Med. 2017; 56(4): 449–53. https://doi.org/10.2169/internalmedicine.56.7620.

47. Ando T, Tochigi N, Gocho K, et al. pathophysiological implication of computed tomography images of chronic pulmonary aspergillosis. Jpn J Infect Dis. 2016; 69(2): 118–26. https://doi.org/10.7883/yoken.JJID.2015.028.

48. Desai SR, Hedayati V, Patel K, Hansell DM. Chronic aspergillosis of the lungs: unravelling the terminology and radiology. Eur Radiol. 2015; 25(10): 3100–7. https://doi.org/10.1007/s00330-015-3690-7.

49. Araújo D, Figueiredo M, Monteiro P. Endobronchial aspergilloma: an unusual presentation of pulmonary aspergillosis. Rev Port Pneumol. 2016; 22(1): 61–2. https://doi.org/10.1016/j.rppnen.2015.07.003.

50. Jiang S, Jiang L, Shan F, et al. Two cases of endobronchial aspergilloma with lung cancer: a review the literature of endobronchial aspergilloma with underlying malignant lesions of the lung. Int J Clin Exp Med. 2015; 8(9): 17015–21.

51. Mrabet FZ, Soualhi M, Achrane J, et al. The tree that hides the forest: aspergillosis associated with bronchial carcinoma (about two cases). Pan Afr Med J. 2017; 28: 302. https://doi.org/10.11604/pamj.2017.28.302.11665.

52. Huang D, Li B, Chu H, et al. Endobronchial aspergilloma: a case report and literature review. Exp Ther Med. 2017; 14(1): 547–54. https://doi.org/10.3892/etm.2017.4540.

53. He B, Wan C, Zhou W, et al. Clinical profile and surgical outcome for different typeof chronic pulmonary aspergillosis. Am J Transl Res. 2019; 11(6): 3671–9.

54. Kosmidis C, Newton P, Muldoon EG, Denning DW. Chronic fibrosing pulmonary aspergillosis: a cause of ‘destroyed lung’ syndrome. Infect Dis (Lond). 2017; 49(4): 296–301. https://doi.org/10.1080/23744235.2016.1232861.

55. Sawahata M, Johkoh T, Kawanobe T, et al. Computed tomography images of fibrotic pulmonary sarcoidosis leading to chronic respiratory failure. J Clin Med. 2020; 9(1): 142. https://doi.org/10.3390/jcm9010142.

56. Kang N, Park J, Jhun BW. Clinical сharacteristics and treatment outcomes of pathologically confirmed aspergillus nodules. J Clin Med. 2020; 9(7): 2185. https://doi.org/10.3390/jcm9072185.

57. Muldoon EG, Sharman A, Page I, et al. Aspergillus nodules; another presentation of chronic pulmonary aspergillosis. BMC Pulm Med. 2016; 16(1): 123. https://doi.org/10.1186/s12890-016-0276-3.

58. Bongomin F, Harris C, Hayes G, et al. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS One. 2018; 13(4): e0193732. https://doi.org/10.1371/journal.pone.0193732.

59. Godet C, Laurent F, Bergeron A, et al. CT imaging assessment of response to treatment in chronic pulmonary aspergillosis. Chest. 2016; 150(1): 139–47. https://doi.org/10.1016/j.chest.2016.02.640.

60. Bongomin F, Otu A, Harris C, et al. Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy. Clin Infect Pract. 2020; 5: 100017. https://doi.org/10.1016/j.clinpr.2020.100015.

61. Ito Y, Tanigawa M, Takemura T, et al. Chronic nodular pulmonary aspergillosis in a patient with rheumatoid arthritis. Intern Med. 2019; 58(7): 979–84. https://doi.org/10.2169/internalmedicine.1918-18.

62. Farid S, Mohamed S, Devbhandari M, et al. Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence – a National Centre’s experience. J Cardiothorac Surg. 2013; 8: 180. https://doi.org/10.1186/1749-8090-8-180.

63. Kim TH, Koo HJ, Lim CM, et al. Risk factors of severe hemoptysis in patients with fungus ball. J Thorac Dis. 2019; 11(10): 4249–57. https://doi.org/10.21037/jtd.2019.09.52.

64. Ando T, Kawashima M, Masuda K, et al. Exacerbation of chronic pulmonary aspergillosis was associated with a high rebleeding rate after bronchial artery embolization. Respir Investig. 2019; 57(3): 260–7. https://doi.org/10.1016/j.resinv.2018.12.009.

65. Sato H, Okada F, Matsumoto S, et al. The scab-like sign: a CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis? 2018; 28(10): 4053–61. https://doi.org/10.1007/s00330-018-5434-y.


Для цитирования:


Николаева Н.Г., Шадривова О.В., Ицкович И.Э., Климко Н.Н. Хронический аспергиллез легких: обзор литературы и демонстрация собственных наблюдений. Вестник рентгенологии и радиологии. 2021;102(5):317-328. https://doi.org/10.20862/0042-4676-2021-102-5-317-328

For citation:


Nikolaeva N.G., Shadrivova O.V., Itskovich I.E., Klimko N.N. Chronic Pulmonary Aspergillosis: Literature Review and Demonstration of Own Observations. Journal of radiology and nuclear medicine. 2021;102(5):317-328. (In Russ.) https://doi.org/10.20862/0042-4676-2021-102-5-317-328

Просмотров: 55


ISSN 0042-4676 (Print)
ISSN 2619-0478 (Online)